Inizia
The-Trend-is-the-Friend

TEVA - Double Bottom?

Long
Teva Pharmaceutical Industries Limited (NYSE:TEVA)  
The-Trend-is-the-Friend  
NYSE:TEVA   Teva Pharmaceutical Industries Limited
Trend Analysis Fundamental Analysis Double Bottom fibonaccianalysis trend intrinsicvalue cashflow
2
2
trendanalysis fundamental doublebottom fibonaccianalysis trend intrinsicvalue cashflow
TEVA has been a repair story now for many years. With litigation in the process of being resolved, debt burdens of $2 bn. per year appear manageable with cash flow - TEVA is moving away from a debt/litigation story
to an equity story. Cash Flow of $3bn + per year, Net Income of ~ 2bn.+.... warrant a blended Intrinsic Value of ~ $22 per share. TEVA's technicals show a textbook double bottom with positive divergence. Reverting to trends and fibonacci levels confirm $22 target.
Declinazione di responsabilità

Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.